Intrinsic Value of S&P & Nasdaq Contact Us

Alto Neuroscience, Inc. ANRO NYSE

NYSE • Healthcare • Biotechnology • US • USD

SharesGrow Score
40/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$26.33
+3.4%

Stock Statistics — ANRO

Alto Neuroscience, Inc. (ANRO) has a market capitalization of $813.65M and trades at $25.47. The 52-week range is 1.64-25.17.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -11.6, Earnings Per Share (EPS) of $-2.19.

The stock has a beta of 2.06, operates in the Healthcare sector.

Trading Data
Current Price$25.47
52-Week Range1.64-25.17
Volume330.97K
Avg Volume (30D)277.51K
Market Cap$813.65M
Beta (1Y)2.06
Company
IPO Date2024-02-02
Employees76
CEOAmit Etkin
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS02157Q1094
CUSIP02157Q109
Income (Latest Year)
Gross Profit$-661K
EBITDA$-65.7M
Operating Income$-66.36M
Net Income$-63.24M
EPS$-2.19
EPS Diluted$-2.19
Shares Outstanding$28.85M
Balance Sheet (Latest Year)
Total Assets$184.69M
Current Assets$177.72M
Cash & ST Investments$176.48M
Total Liabilities$33.55M
Total Debt$4.41M
Net Debt$-172.08M
Total Equity$151.14M
Debt / Equity0.03
Valuation Ratios
P/E Ratio-11.6
P/B Ratio5.38
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message